Join Here   |   Log In

Multiple Chemical Sensitivity (MCS): Genetics, Causes, and Solutions

Key takeaways:
~ Multiple chemical sensitivity is a systemic response to common environmental chemicals that don’t normally cause reactions.
~ Genetic research points to interactions between detoxification genes and the olfactory system.
~ Targeting the right genetic pathways may help alleviate reactions.

Members will see their genotype report below and the solutions in the Lifehacks section. Consider joining today

What is Multiple Chemical Sensitivity (MCS)?

Multiple chemical sensitivity is a condition in which low-level exposures to common environmental chemicals cause systemic reactions. For example, some people are sensitive to smells such as pesticides or solvents, causing headaches, sinus drainage, joint pain, and more.

Multiple chemical sensitivity (MCS) is also known in research studies as Chemical Sensitivity, Chemical Intolerance, Idiopathic Environmental Illness, and Toxicant-Induced Loss of Tolerance. It is sometimes considered a part of Sensitivity-Related Illnesses or mold reactions.

MCS is often initially caused by a sensitizing event, such as a strong exposure to a specific chemical. It may then shift to include a generalized response that is triggered by a larger set of chemicals.[ref]

Many researchers consider MCS to be a loss of tolerance to environmental contaminants, such as organophosphates, solvents, and heavy metals, even at concentrations considered non-toxic for most people.
Symptoms of Multiple Chemical Sensitivity include:

Symptom Description/Example
Hypersensitivity Smell of chemicals, scents seem strong
Headaches Often after exposure
Fatigue More than tiredness, brain fog
Respiratory Issues Chest/throat pain, watery eyes upon exposure
Joint Pain Discomfort continues after exposures
Mood/Cognitive Brain fog, anxiety, depression

Research on people with MCS shows that it is slightly more common in women than in men.

A recent cohort study looked at the physiological differences between people with MCS who had no other comorbidities (e.g., no fibromyalgia or autoimmune diseases) and an age- and health-matched control group. People with MCS were more likely to have lower blood pressure, lower handgrip strength, and higher BMI.[ref]

Common Triggers and Environmental Factors

Some of the commonly cited offenders include new cars, new furniture, new clothes, mold, carpeting, dust, anything with artificial fragrances, car exhaust, food preservatives, chlorinated water, cigarette smoke, detergents, skin care products, and paint.

Volatile organic compounds (VOCs) are often released indoors from furniture and building products. Research shows VOC levels are ~4 times higher indoors. VOCs often trigger reactions in people with MCS.

Semi-volatile organic compounds (SVOCs) are also released indoors from cleaning products, detergents, synthetic fragrances, pest control sprays, furniture, and plastics.[ref]

Here is a graph of common triggers from a Danish study on MCS:[ref]

PMC7904225

History of MCS:

Multiple Chemical Sensitivity was first described in the 1950s by an allergist named Theron Randolph. Much of what Randolph wrote is considered pseudoscience by the medical community, and the American Medical Association still doesn’t recognize MCS as a disease.

Other countries, such as Germany, Denmark, Finland, Spain, and Austria, do recognize MCS as a disease. The CDC recognizes multiple chemical sensitivity as part of ME/CFS.[ref][ref]

Prevalence:

Studies on MCS are all over the place as to how common it is, which is likely due to different ways of defining the condition. MCS is estimated to affect 0.5-6.5% of the medically diagnosed population, while self-diagnosed cases make up 9.0-11.2% of the general population, according to one paper.

The lack of consensus on diagnostic criteria makes it difficult to know exactly how many people have MCS. A more recent Danish population-based cohort study put the prevalence at 1.95%, while a recent study in the U.S., Australia, UK, and Sweden reported that 7.4% of the population had MCS.[ref]

Is multiple chemical sensitivity psychosomatic?

For many years, the lack of recognition by medical authorities has led many people to question whether MCS is “all in their head” or psychosomatic. Labels such as psychogenic or psychosomatic are applied by doctors, in part, because of a statistical correlation with higher levels of depression and anxiety.[ref]

However, the physiological and cellular changes in people with chemical sensitivities are measurable, statistically significant, and visible, strongly suggesting a physiological cause rather than a psychological cause.[ref][ref]

On the other hand, there are several clinical trials using specific solvents or chemical odors that found no statistical change in measured parameters (e.g. blood pressure, heart rate). [ref][ref] However, the lack of change in autonomic function due to a specific chemical may not be the right variable to control for. People with MCS tend to react systemically in different ways and to different chemicals due to individual past exposures.

Underlying biology in MCS:

Let’s dive into more of the research on what is going on in the body with MCS.

Olfactory system and detoxification:

People with multiple chemical sensitivity are often very sensitive to odors, prompting a lot of research into whether MCS is caused by genetic or other changes to the olfactory system.

Odors are simply the way our brain perceives the stimulus of a specific compound binding to an olfactory receptor in the nose.

We have a number of different odor receptors that detect different compounds. When these receptors are activated in the nose, they send a signal to the brain – letting us know that cookies are baking or that the grass has just been cut. However, the same receptors are found in other parts of the body and can bind to compounds.

Studies of odor detection thresholds don’t show a statistically significant difference in people with MCS. Genetic studies also don’t show that genes related to odor receptors are associated with MCS. Thus, it doesn’t seem likely that hypersensitivity to odors is the problem.[ref]

Instead, much of the research points to hyper-reactivity to certain compounds, possibly due to altered detoxification pathways.[ref]

Oxidative Stress in Multiple Chemical Sensitivity:

Scientists have approached MCS from many angles, using genetic, metabolic, immunologic, etiologic, symptomatic, therapeutic, and epidemiologic tools.

The role of oxidative stress in the development of MCS is now widely accepted, along with alterations in redox status that contribute to chronic mild systemic inflammation.

Patients with MCS exhibit elevated oxidative status and inflammatory markers compared to their healthy counterparts.[ref]

MCS patients also have lower glutathione levels.[ref] Glutathione is a naturally produced antioxidant and one of the main ways that our cells fight oxidative stress.

Genetic variants related to phase I and phase II detoxification of xenobiotic compounds are linked to multiple chemical sensitivity. Phase I and Phase II detoxification are two stages of the body’s natural process for breaking down and eliminating potentially harmful substances, including drugs, toxins, and metabolic waste products.

Detoxification overview
Phase Enzymes Action Result
Phase I CYP450 Makes toxins more reactive and polar Prepares for Phase II
Phase II GST, UGTs, SULTs others Water-soluble conjugates for elimination Excretes via urine/sweat

A mismatch between the breakdown rate of compounds in phase I and phase II can cause oxidative stress in the cells. For example, if a phase I metabolite can’t be cleared out quickly enough with phase II conjugation, then it can cause oxidative stress.

One way that this could cause the symptoms seen in MCS is that oxidative stress can cause neurogenic inflammation due to the vulnerability of the central nervous system to free radicals.[ref]

Combination of oxidative stress and odorant reactions?

Another possibility involves the detoxification genes acting on odorants within the nose – or, rather, not responding to odorants appropriately.

Linking the olfactory system and the detoxification system, animal studies show that GST (glutathione s-transferase) and CYP450 enzymes actually participate in odorant clearance and the olfactory process.

The GST genes are expressed in the nasal mucosa. Experiments have shown that odors that are glucuronoconjugated (using the UGT genes) elicit the lowest olfactory response. Other experiments show that the GST enzymes are essential for how animals detect odors and respond to pheromones.[ref]

PMC9541901

Transdermal route:
Odorants are inhaled, of course, but some, such as essential oils, sulfur compounds, and terpenes, can also be absorbed through the skin. Once an odorant is absorbed into the body, it is either distributed in the circulation or biotransformed (e.g. by CYP 450 enzymes).

Stored in fat:
Interestingly, lipophilic (fat-soluble) odorants are often stored in your fat tissue.[ref]

A recent Danish study found that people with MCS were more likely to have a higher waist circumference and body fat percentage than an age and health-matched control group without MCS.[ref] Perhaps this indicates that more of the lipophilic odorants are stored in fat.

TRPs in MCS: Ion channel activation

Transient receptor potential (TRP) receptors are a family of ion channels expressed in the nervous system. These receptors act as cellular sensors of physical stimuli.

Imaging studies of the brains of people with MCS show that TRPV1 and TRPA1 are overly sensitized.[ref]

  • TRPV1 senses volatile compounds such as toluene, styrene, benzene, ethylbenzene, acetone, diethyl ether, hexane, heptane, cyclohexane, and formaldehyde. TRPV1 is also activated by capsaicin (hot peppers), low extracellular pH, and noxious heat.[ref]
  • TRPA1 is activated by VOCs, cigarette smoke, heavy metals, naphthalene (moth balls), formaldehyde, and styrene.[ref]

TRP receptors are highly expressed in the olfactory and trigeminal nerve endings and in the brain.  TRPV1 is expressed in about 60% of vagal neurons, and TRPA1 in about 25%.[ref] In addition to chemical stimuli, TRP receptors respond to oxidative stress and systemic inflammation.[ref]

Repeated activation and hyperexcitability:
TRPA1 and TRPV1 receptors are often co-localized on the same cells. Repeated activation of the receptors can lead to upregulation and sensitization, causing hyperexcitability of the receptor even at low levels.

Importantly for MCS, the two receptors modulate and sensitize each other. For example, the sensitization of TRPA1 with a low dose exposure to acrolein causes sensitization of TRPV1 against capsaicin.[ref]

Studies in workplaces that have high VOC levels show that TRPA1 activation is “the molecular initial event (MIE) leading to sensory irritation.”[ref]

A 2022 study investigated the sensitivity to capsaicin, a TRPV1 receptor activator, in people with MCS compared to a control group. The results showed that capsaicin provoked significantly more symptoms in MCS patients than in healthy controls.[ref]

Mold, infections, and pesticides:

Mold toxins also trigger MCS in some people. Exposure to “dampness microbiota” in a building that has moisture problems increases the relative risk of multiple chemical sensitivity by about 3-fold.[ref]

Research also shows that having a significant infection in the past decade, either viral or bacterial, is linked to an increased relative risk of MCS. [ref]

One study of people who react to building interiors looked specifically at acrolein, an aldehyde that has an acrid odor. Acrolein is used as a herbicide and algaecide, but it is also produced by the burning of fossil fuels, cigarette smoke, burning fats, and the oxidation of volatile organic compounds that are emitted in new construction. The people in the study with known chemical sensitivities detected acrolein at low levels and had more eye, nose, and throat symptoms after about 30 minutes of exposure.[ref]

Gut microbiome and MCS:

A study involving 30 adults with MCS in Japan looked at the gut microbiome composition and compared it to an age and sex-matched control group. The results showed that “Akkermansia muciniphila was significantly more abundant (p = 0.02, fold change = 3.3) and Faecalibacterium prausnitzii significantly less abundant in MCS patients than in HC (p = 0.03, fold change = 0.53).”  They also found that xylene and dioxin degradation pathways were upregulated.[ref]

Interestingly, Akkermansia muciniphila is currently being promoted as a probiotic. It is associated with healthy body weight, and it produces short-chain fatty acids that are used by other gut microbes. However, Akkermansia muciniphila also eats your gut mucosal layer. It could be that the 3-fold higher abundance of Akkermansia muciniphila in MCS patients decreases their gut mucosal barrier and activates the body’s immune response.[ref]

 

Now let’s take a look at how your genetic variants increase or decrease your susceptibility to MCS.


Multiple Chemical Sensitivity Genotype Report:

Access this content:

An active subscription is required to access this content.

Join as a member



Lifehacks: Natural Solutions for Multiple Chemical Sensitivity

Lifestyle changes:

If you have been dealing with MCS for a while, you probably already know and understand which chemicals are likely to trigger symptoms. However, here are some suggestions that may help if you are new to MCS. Of course, talk to your doctor for any medical advice.

Improve indoor air quality:
Studies show that improving indoor air quality can help significantly reduce MCS symptoms. The “Environmental House Call” study looked at the effects of recommended interventions such as eliminating cleaning products, personal care products, and laundry products with fragrances and VOCs. Additionally, carpets and major outgassing sources were removed. [ref]

graph showing MCS interventions to improve indoor air quality
Changes in symptoms for MCS patients improving their indoor air quality by following the expert advice from an “Environmental House Call”

Laundry detergents and fabric softeners:
Laundry products are notorious for fragrances that trigger MCS symptoms.  Look for detergents that say “Free and Clear” or “Free and Clear with Odor Remover”. Keep in mind that fragrance-free cleaners and laundry products may still contain VOCs.[ref]

  • Try washing with vinegar, baking soda, or soap nuts (if you are comfortable with the natural scent).
  • Keep in mind that it may take several washes to remove previously scented detergent and fabric softener odors from clothing.

Home and travel:
There’s a website called Find a Pure Hotel Room that lists hotels that are free of fragrances and contaminants. This may be a good place to check if you are planning to travel.

My Chemical-free House is a website run by someone with MCS. It has many suggestions for non-toxic and scent-free home and building products.

Air purifiers:
Reducing indoor air pollution from off-gassing and VOCs can be helpful, and air purifiers are a good option here. HEPA filters and UV light can help if mold spores are one of your triggers.

Organic:
Eating organic whenever possible helps to reduce exposure to pesticide residues on food.

Natural fragrances:
Essential oils and natural fragrances may still bother some people with MCS, so look for personal care products that are labeled fragrance-free rather than with natural scents.

Genetic connections:

Let’s look at possible solutions for specific genetic variants.

GSTM1 null variant:

Access this content:

An active subscription is required to access this content.

Join as a member



Related Articles and Topics:

Chronic Inflammation: Causes and Natural Solutions


References:

Al-Maghrebi, May, et al. “Manganese Supplementation Relieves the Phenotypic Deficits Seen in Superoxide-Dismutase-Null Escherichia Coli.” Archives of Biochemistry and Biophysics, vol. 402, no. 1, June 2002, pp. 104–09. PubMed, https://doi.org/10.1016/S0003-9861(02)00065-6.
Andersson, Linus, et al. “Chemosensory Perception, Symptoms and Autonomic Responses during Chemical Exposure in Multiple Chemical Sensitivity.” International Archives of Occupational and Environmental Health, vol. 89, no. 1, Jan. 2016, pp. 79–88. PubMed, https://doi.org/10.1007/s00420-015-1053-y.
Bjerregaard, Anne A., et al. “Physiological Health and Physical Performance in Multiple Chemical Sensitivity—Described in the General Population.” International Journal of Environmental Research and Public Health, vol. 19, no. 15, July 2022, p. 9039. PubMed Central, https://doi.org/10.3390/ijerph19159039.
Bornschein, Susanne, et al. “Double-Blind Placebo-Controlled Provocation Study in Patients with Subjective Multiple Chemical Sensitivity (MCS) and Matched Control Subjects.” Clinical Toxicology (Philadelphia, Pa.), vol. 46, no. 5, June 2008, pp. 443–49. PubMed, https://doi.org/10.1080/15563650701742438.
Cannata, Attilio, Chiara De Luca, Giulia Andolina, et al. “Influence of the SOD2 A16V Gene Polymorphism on Alterations of Redox Markers and Erythrocyte Membrane Fatty Acid Profiles in Patients with Multiple Chemical Sensitivity.” Biomedical Reports, vol. 15, no. 6, Dec. 2021, p. 101. PubMed Central, https://doi.org/10.3892/br.2021.1477.
Cannata, Attilio, Chiara De Luca, Liudmila G. Korkina, et al. “The SNP Rs2298383 Reduces ADORA2A Gene Transcription and Positively Associates with Cytokine Production by Peripheral Blood Mononuclear Cells in Patients with Multiple Chemical Sensitivity.” International Journal of Molecular Sciences, vol. 21, no. 5, Mar. 2020, p. 1858. PubMed Central, https://doi.org/10.3390/ijms21051858.
Childs, Emma, et al. “Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety.” Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, vol. 33, no. 12, Nov. 2008, pp. 2791–800. PubMed, https://doi.org/10.1038/npp.2008.17.
Dantoft, Thomas Meinertz, et al. “Multiple Chemical Sensitivity Described in the Danish General Population: Cohort Characteristics and the Importance of Screening for Functional Somatic Syndrome Comorbidity—The DanFunD Study.” PLoS ONE, vol. 16, no. 2, Feb. 2021, p. e0246461. pmc.ncbi.nlm.nih.gov, https://doi.org/10.1371/journal.pone.0246461.
De Luca, Chiara, Maria G. Scordo, et al. “Biological Definition of Multiple Chemical Sensitivity from Redox State and Cytokine Profiling and Not from Polymorphisms of Xenobiotic-Metabolizing Enzymes.” Toxicology and Applied Pharmacology, vol. 248, no. 3, Nov. 2010, pp. 285–92. PubMed, https://doi.org/10.1016/j.taap.2010.04.017.
De Luca, Chiara, Agnese Gugliandolo, et al. “Role of Polymorphisms of Inducible Nitric Oxide Synthase and Endothelial Nitric Oxide Synthase in Idiopathic Environmental Intolerances.” Mediators of Inflammation, vol. 2015, 2015, p. 245308. PubMed Central, https://doi.org/10.1155/2015/245308.
Gallo, Valentina, et al. “TRPA1 Gene Polymorphisms and Childhood Asthma.” Pediatric Allergy and Immunology, vol. 28, no. 2, Mar. 2017, pp. 191–98. PubMed Central, https://doi.org/10.1111/pai.12673.
GSTM1 Glutathione S-Transferase Mu 1 [Homo Sapiens (Human)] – Gene – NCBI. https://www.ncbi.nlm.nih.gov/gene?cmd=Retrieve&dopt=full_report&list_uids=2944. Accessed 4 Mar. 2026.
Hauge, Christian Riise, et al. “Mindfulness-Based Cognitive Therapy (MBCT) for Multiple Chemical Sensitivity (MCS): Results from a Randomized Controlled Trial with 1 Year Follow-Up.” Journal of Psychosomatic Research, vol. 79, no. 6, Dec. 2015, pp. 628–34. PubMed, https://doi.org/10.1016/j.jpsychores.2015.06.010.
Haumann, Katja, et al. “Breathing and Heart Rate during Experimental Solvent Exposure of Young Adults with Self-Reported Multiple Chemical Sensitivity (sMCS).” Neurotoxicology, vol. 24, no. 2, Mar. 2003, pp. 179–86. PubMed, https://doi.org/10.1016/S0161-813X(02)00213-9.
Heydel, Jean-Marie, et al. “Characterization of Rat Glutathione Transferases in Olfactory Epithelium and Mucus.” PLoS ONE, vol. 14, no. 7, July 2019, p. e0220259. PubMed Central, https://doi.org/10.1371/journal.pone.0220259.
Hohoff, Christa, et al. “Adenosine A(2A) Receptor Gene: Evidence for Association of Risk Variants with Panic Disorder and Anxious Personality.” Journal of Psychiatric Research, vol. 44, no. 14, Oct. 2010, pp. 930–37. PubMed, https://doi.org/10.1016/j.jpsychires.2010.02.006.
Hypoallergenic Hotel Rooms | Pure Wellness. https://www.pureroom.com/find-a-pure-room. Accessed 4 Mar. 2026.
Hyvönen, Saija, et al. “High Prevalence of Neurological Sequelae and Multiple Chemical Sensitivity among Occupants of a Finnish Police Station Damaged by Dampness Microbiota.” Archives of Environmental & Occupational Health, vol. 76, no. 3, Apr. 2021, pp. 145–51. DOI.org (Crossref), https://doi.org/10.1080/19338244.2020.1781034.
Kornbausch, Nicole, et al. “Odorant Metabolism in Humans.” Angewandte Chemie (International Ed. in English), vol. 61, no. 35, Aug. 2022, p. e202202866. PubMed Central, https://doi.org/10.1002/anie.202202866.
Ma, Xiao, et al. “The Effect of Diaphragmatic Breathing on Attention, Negative Affect and Stress in Healthy Adults.” Frontiers in Psychology, vol. 8, June 2017. Frontiers, https://doi.org/10.3389/fpsyg.2017.00874.
Martinez, Jeanelle M., and Thomas E. Eling. “Activation of TRPA1 by Volatile Organic Chemicals Leading to Sensory Irritation.” ALTEX, vol. 36, no. 4, 2019, pp. 572–82. PubMed Central, https://doi.org/10.14573/altex.1811012.
Micarelli, Alessandro, et al. “Olfactory-Related Quality of Life in Multiple Chemical Sensitivity: A Genetic-Acquired Factors Model.” International Journal of Molecular Sciences, vol. 21, no. 1, Dec. 2019, p. 156. PubMed Central, https://doi.org/10.3390/ijms21010156.
Molot, John, Margaret Sears, and Hymie Anisman. “Multiple Chemical Sensitivity: It’s Time to Catch up to the Science.” Neuroscience & Biobehavioral Reviews, vol. 151, Aug. 2023, p. 105227. ScienceDirect, https://doi.org/10.1016/j.neubiorev.2023.105227.
Molot, John, Margaret Sears, Lynn Margaret Marshall, et al. “Neurological Susceptibility to Environmental Exposures: Pathophysiological Mechanisms in Neurodegeneration and Multiple Chemical Sensitivity.” Reviews on Environmental Health, vol. 37, no. 4, Dec. 2022, pp. 509–30. www.degruyterbrill.com, https://doi.org/10.1515/reveh-2021-0043.
“My Chemical-Free House | A Guide to Creating a Healthy Home.” My Chemical-Free House, https://www.mychemicalfreehouse.net/. Accessed 4 Mar. 2026.
Navarro, Sandi L., et al. “Cruciferous Vegetables Have Variable Effects on Biomarkers of Systemic Inflammation in a Randomized Controlled Trial in Healthy Young Adults12.” The Journal of Nutrition, vol. 144, no. 11, Nov. 2014, pp. 1850–57. PubMed Central, https://doi.org/10.3945/jn.114.197434.
Palmquist, Eva, and Anna-Sara Claeson. “Odor Perception and Symptoms during Acrolein Exposure in Individuals with and without Building-Related Symptoms.” Scientific Reports, vol. 12, May 2022, p. 8171. PubMed Central, https://doi.org/10.1038/s41598-022-12370-7.
Perales, Roger B., et al. “Does Improving Indoor Air Quality Lessen Symptoms Associated with Chemical Intolerance?” Primary Health Care Research & Development, vol. 23, Jan. 2022, p. e3. PubMed Central, https://doi.org/10.1017/S1463423621000864.
Prescott, Sara L., and Stephen D. Liberles. “Internal Senses of the Vagus Nerve.” Neuron, vol. 110, no. 4, Feb. 2022, pp. 579–99. PubMed Central, https://doi.org/10.1016/j.neuron.2021.12.020.
Qiu, Juanjuan, et al. “Association between Polymorphisms in Estrogen Metabolism Genes and Breast Cancer Development in Chinese Women.” Medicine, vol. 97, no. 47, Nov. 2018, p. e13337. PubMed Central, https://doi.org/10.1097/MD.0000000000013337.
Ramirez, Jan-Marino. “The Integrative Role of the Sigh in Psychology, Physiology, Pathology, and Neurobiology.” Progress in Brain Research, vol. 209, 2014, pp. 91–129. PubMed Central, https://doi.org/10.1016/B978-0-444-63274-6.00006-0.
Rodrigues, Vanessa Fernandes, et al. “Akkermansia Muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes.” Frontiers in Immunology, vol. 13, July 2022, p. 934695. PubMed Central, https://doi.org/10.3389/fimmu.2022.934695.
Rushworth, Gordon F., and Ian L. Megson. “Existing and Potential Therapeutic Uses for N-Acetylcysteine: The Need for Conversion to Intracellular Glutathione for Antioxidant Benefits.” Pharmacology & Therapeutics, vol. 141, no. 2, Feb. 2014, pp. 150–59. PubMed, https://doi.org/10.1016/j.pharmthera.2013.09.006.
Schnakenberg, Eckart, et al. “A Cross-Sectional Study of Self-Reported Chemical-Related Sensitivity Is Associated with Gene Variants of Drug-Metabolizing Enzymes.” Environmental Health, vol. 6, Feb. 2007, p. 6. PubMed Central, https://doi.org/10.1186/1476-069X-6-6.
Schovsbo, Signe Ulfbeck, et al. “Association between Infections and Functional Somatic Disorders: A Cross-Sectional Population-Based Cohort Study.” BMJ Open, vol. 12, no. 11, Nov. 2022, p. e066037. PubMed Central, https://doi.org/10.1136/bmjopen-2022-066037.
Steinemann, Anne. “Volatile Emissions from Common Consumer Products.” Air Quality, Atmosphere & Health, vol. 8, no. 3, June 2015, pp. 273–81. Springer Link, https://doi.org/10.1007/s11869-015-0327-6.
Ternesten-Hasséus, Ewa, et al. “Increased Capsaicin Cough Sensitivity in Patients with Multiple Chemical Sensitivity.” Journal of Occupational and Environmental Medicine, vol. 44, no. 11, Nov. 2002, pp. 1012–17. PubMed, https://doi.org/10.1097/00043764-200211000-00006.
Tran, Marie Thi Dao, et al. “A Randomised, Placebo-Controlled Trial of Transcranial Pulsed Electromagnetic Fields in Patients with Multiple Chemical Sensitivity.” Acta Neuropsychiatrica, vol. 29, no. 5, Oct. 2017, pp. 267–77. PubMed, https://doi.org/10.1017/neu.2016.51.
Wang, Yuqing, et al. “SOD2 Mediates Curcumin-Induced Protection against Oxygen-Glucose Deprivation/Reoxygenation Injury in HT22 Cells.” Evidence-Based Complementary and Alternative Medicine : eCAM, vol. 2019, Sept. 2019, p. 2160642. PubMed Central, https://doi.org/10.1155/2019/2160642.
Watai, Kentaro, et al. “Metagenomic Gut Microbiome Analysis of Japanese Patients with Multiple Chemical Sensitivity/Idiopathic Environmental Intolerance.” BMC Microbiology, vol. 24, no. 1, Mar. 2024, p. 84. PubMed, https://doi.org/10.1186/s12866-024-03239-y.
Zucco, Gesualdo M., and Richard L. Doty. “Multiple Chemical Sensitivity.” Brain Sciences, vol. 12, no. 1, Dec. 2021, p. 46. PubMed Central, https://doi.org/10.3390/brainsci12010046.

About the Author:
Debbie Moon is a biologist, engineer, author, and the founder of Genetic Lifehacks where she has helped thousands of members understand how to apply genetics to their diet, lifestyle, and health decisions. With more than 10 years of experience translating complex genetic research into practical health strategies, Debbie holds a BS in engineering from Colorado School of Mines and an MSc in biological sciences from Clemson University. She combines an engineering mindset with a biological systems approach to explain how genetic differences impact your optimal health.